Matthew D. Griffin

17.5k total citations · 4 hit papers
204 papers, 12.7k citations indexed

About

Matthew D. Griffin is a scholar working on Surgery, Nephrology and Genetics. According to data from OpenAlex, Matthew D. Griffin has authored 204 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 40 papers in Nephrology and 39 papers in Genetics. Recurrent topics in Matthew D. Griffin's work include Mesenchymal stem cell research (37 papers), Renal Transplantation Outcomes and Treatments (24 papers) and Tissue Engineering and Regenerative Medicine (17 papers). Matthew D. Griffin is often cited by papers focused on Mesenchymal stem cell research (37 papers), Renal Transplantation Outcomes and Treatments (24 papers) and Tissue Engineering and Regenerative Medicine (17 papers). Matthew D. Griffin collaborates with scholars based in United States, Ireland and Mexico. Matthew D. Griffin's co-authors include Thomas Ritter, Mark D. Stegall, Aideen E. Ryan, Rajiv Kumar, Timothy S. Larson, Lori A. Bachman, Sweta Rani, Fernando G. Cosio, Joseph P. Grande and D J McKean and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Matthew D. Griffin

193 papers receiving 12.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications

2015 940 citations Aideen E. Ryan, Matthew D. Griffin et al. profile →
Molecular Basis of T Cell Inactivation by CTLA-4

1998 557 citations Kyung‐Mi Lee, Matthew D. Griffin et al. profile →
Inflammation in AKI

2015 444 citations Matthew D. Griffin et al. Journal of the American Society of Nephrology profile →
Empagliflozin in Heart Failure

2020 270 citations Matthew D. Griffin, Veena S. Rao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew D. Griffin United States	61	3.0k	3.0k	2.8k	2.6k	2.0k	204	12.7k
Fokko J. van der Woude Netherlands	59	2.0k 0.7×	2.7k 0.9×	2.4k 0.9×	2.1k 0.8×	2.7k 1.3×	261	13.5k
Hans J. Schlitt Germany	65	2.5k 0.8×	7.1k 2.4×	2.2k 0.8×	1.6k 0.6×	590 0.3×	510	15.7k
Anil Chandraker United States	50	1.9k 0.6×	2.5k 0.9×	2.8k 1.0×	2.5k 1.0×	760 0.4×	194	9.1k
Patrick Niaudet France	61	4.6k 1.5×	1.0k 0.3×	3.1k 1.1×	1.2k 0.5×	6.5k 3.2×	295	13.4k
Jan N.M. IJzermans Netherlands	67	1.9k 0.6×	9.0k 3.0×	1.6k 0.6×	2.3k 0.9×	747 0.4×	658	19.8k
Neeraja Kambham United States	42	2.2k 0.8×	1.3k 0.4×	2.1k 0.7×	1.3k 0.5×	1.6k 0.8×	118	8.2k
Carla C. Baan Netherlands	53	2.2k 0.7×	3.2k 1.1×	3.4k 1.2×	2.7k 1.1×	360 0.2×	371	10.3k
Paola Romagnani Italy	68	5.5k 1.9×	2.7k 0.9×	6.6k 2.4×	380 0.1×	3.9k 1.9×	236	18.9k
Leendert A. van Es Netherlands	51	1.7k 0.6×	1.4k 0.5×	4.1k 1.5×	1.1k 0.4×	3.1k 1.5×	235	12.0k
Jean‐Paul Soulillou France	58	1.5k 0.5×	3.7k 1.2×	4.5k 1.6×	4.7k 1.8×	971 0.5×	342	11.2k

Countries citing papers authored by Matthew D. Griffin

Since Specialization

Citations

This map shows the geographic impact of Matthew D. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Griffin more than expected).

Fields of papers citing papers by Matthew D. Griffin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Griffin. The network helps show where Matthew D. Griffin may publish in the future.

Co-authorship network of co-authors of Matthew D. Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Griffin. A scholar is included among the top collaborators of Matthew D. Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Griffin. Matthew D. Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cormican, Sarah, Omri Teltsh, Matthew D. Griffin, et al.. (2025). Characterization of Monogenic Kidney Disease in Older Patients With CKD. Kidney International Reports. 10(7). 2140–2152.

Weleff, Jeremy, et al.. (2025). Changes in Local Community Spatial Trends of Motor Vehicle Accidents Near Cannabis Dispensaries after Recreational Cannabis Legalization. Cannabis and Cannabinoid Research. 1327021959–1327021959.

Buckley, Claire, et al.. (2024). Social deprivation and diabetic kidney disease: A European view. Journal of Diabetes Investigation. 15(5). 541–556. 3 indexed citations

Iselin, Katja, Jesper Hjortdal, W. John Armitage, et al.. (2024). Outcomes after reversed corneal graft rejection: a report from the European VISICORT project. BMJ Open Ophthalmology. 9(1). e001554–e001554.

Ryan, Christina N. M., Eugenia Pugliese, Naledi Shologu, et al.. (2022). The synergistic effect of physicochemical in vitro microenvironment modulators in human bone marrow stem cell cultures. Biomaterials Advances. 144. 213196–213196. 8 indexed citations

Griffin, Matthew D., et al.. (2022). Anti-PR3 Positive Pauci-Immune Glomerulonephritis Associated With Immune Checkpoint Inhibitor Therapy and Responsive to Corticosteroid and Rituximab. Journal of the American Society of Nephrology. 33(11S). 374–374.

White, Arthur, Cathal Walsh, Louis J. M. Aslett, et al.. (2022). Extended data for 'ANCA-associated vasculitis in Ireland: a multi-centre national cohort study'. Zenodo (CERN European Organization for Nuclear Research).

Cormican, Sarah & Matthew D. Griffin. (2021). Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?. Frontiers in Immunology. 12. 664202–664202. 44 indexed citations

Moran, Sarah, Jennifer Scott, Michael R. Clarkson, et al.. (2021). The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology. 32(11). 2920–2932. 25 indexed citations

10.

Rao, Veena S., Juan B. Ivey‐Miranda, Zachary L. Cox, et al.. (2021). Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure. Journal of the American College of Cardiology. 77(6). 695–708. 41 indexed citations

11.

Griffin, Matthew D., Veena S. Rao, James H. Fleming, et al.. (2019). Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure. The American Journal of Cardiology. 124(11). 1707–1711. 17 indexed citations

12.

Bian, Xiaohui, Tomás P. Griffin, Xiangyang Zhu, et al.. (2019). Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy. BMJ Open Diabetes Research & Care. 7(1). e000720–e000720. 44 indexed citations

13.

Dennedy, Michael Conall, et al.. (2016). Infliximab Selectively Modulates the Circulating Blood Monocyte Repertoire in Crohnʼs Disease. Inflammatory Bowel Diseases. 22(12). 2863–2878. 10 indexed citations

14.

Lohan, Paul, Cynthia M. Coleman, Mary Murphy, et al.. (2014). Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?. Stem Cell Research & Therapy. 5(4). 99–99. 60 indexed citations

15.

Wadei, Hani M., Hatem Amer, Sandra J. Taler, et al.. (2007). Diurnal Blood Pressure Changes One Year after Kidney Transplantation. Journal of the American Society of Nephrology. 18(5). 1607–1615. 41 indexed citations

16.

Park, Walter D., Matthew D. Griffin, Joseph P. Grande, Fernando G. Cosio, & Mark D. Stegall. (2007). Molecular Evidence of Injury and Inflammation in Normal and Fibrotic Renal Allografts One Year Posttransplant. Transplantation. 83(11). 1466–1476. 31 indexed citations

17.

Graham, Daniel B., Michael P. Bell, Catherine J. Huntoon, et al.. (2006). CD28 Ligation Costimulates Cell Death but Not Maturation of Double-Positive Thymocytes due to Defective ERK MAPK Signaling. The Journal of Immunology. 177(9). 6098–6107. 12 indexed citations

18.

Griffin, Matthew D., David K. Hong, Philmore O. Holman, et al.. (2000). Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152). The Journal of Immunology. 164(9). 4433–4442. 62 indexed citations

19.

Griffin, Matthew D., W Lütz, Vy Phan, et al.. (2000). Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D Analogs. Biochemical and Biophysical Research Communications. 270(3). 701–708. 223 indexed citations

20.

Khattri, Roli, Julie Auger, Matthew D. Griffin, Arlene H. Sharpe, & Jeffrey A. Bluestone. (1999). Lymphoproliferative Disorder in CTLA-4 Knockout Mice Is Characterized by CD28-Regulated Activation of Th2 Responses. The Journal of Immunology. 162(10). 5784–5791. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact